FDA Inspection
Rentschler Biopharma SERentschler Biopharma SE – FDA Inspection, May 5, 2023
Record Details
This FDA Inspection record concerns Rentschler Biopharma SE, with an inspection on May 5, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Rentschler Biopharma SE
- Inspection Date
- May 5, 2023
- Product Type
- Drugs
View Company Profile
ID · 0d912736-9230-4aef-96a6-874067c47f8c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1246782
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Rentschler Biopharma SE
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2023 | Not classified | Office of Inspections and Investigations | |
| February 26, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 9, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2018 | Not classified | Office of Inspections and Investigations | |
| May 23, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Rentschler Biopharma SE
- FDA Inspection 1202157 - 2023-03-07
- FDA Inspection 1160831 - 2021-02-26
- FDA Inspection 1102650 - 2019-08-09
- FDA Inspection 1046488 - 2018-03-08
- FDA Inspection 1022082 - 2017-05-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.